Granulocyte colony-stimulating factor impairs liver regeneration in mice through the up-regulation of interleukin-1β

Journal of Hepatology

Volumn 47, Issue 6, 2007, Pages 816-825

  Ogiso, Tomio ^a   Nagaki, Masahito ^a   Takai, Shinji ^a   Tsukada, Yoshihiko ^a   Mukai, Tsuyoshi ^a   Kimura, Kiminori ^a   Moriwaki, Hisataka ^a  

^a GIFU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Apoptosis; Cytokine; Hepatic fibrosis; Neutrophil; Stem cell

Indexed keywords

ANTIBODY; ANTIMURINE INTERLEUKIN 1BETA ANTIBODY; CHEMOKINE; CYCLINE; CYTOKINE; DIMETHYLNITROSAMINE; GRANULOCYTE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN G; INTERLEUKIN 1BETA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CYCLE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; FEMALE; LIVER FIBROSIS; LIVER REGENERATION; MOUSE; NONHUMAN; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; STAINING; SURVIVAL; UPREGULATION;

ANIMALS; ANTIBODIES; DIMETHYLNITROSAMINE; GRANULOCYTE COLONY-STIMULATING FACTOR; IMMUNIZATION, PASSIVE; INTERLEUKIN-1BETA; LIVER CIRRHOSIS; LIVER REGENERATION; MICE; MICE, INBRED ICR; RNA, MESSENGER; SURVIVAL RATE; UP-REGULATION;

EID: 35748946620     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2007.06.017     Document Type: Article

References (42)

1. Michalopoulos G.K., and DeFrances M.C. Liver regeneration. Science 276 (1997) 60-66
2. Brazelton T.R., Rossi F.M., Keshet G.I., and Blau H.M. From marrow to brain: expression of neuronal phenotypes in adult mice. Science 290 (2000) 1775-1779
3. Ferrari G., Cusella-De Angelis G., Coletta M., Paolucci E., Stornaiuolo A., Cossu G., et al. Muscle regeneration by bone marrow-derived myogenic progenitors. Science 279 (1998) 1528-1530
4. Krause D.S., Theise N.D., Collector M.I., Henegariu O., Hwang S., Gardner R., et al. Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell. Cell 105 (2001) 369-377
5. Lagasse E., Connors H., Al-Dhalimy M., Reitsma M., Dohse M., Osborne L., et al. Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Nat Med 6 (2000) 1229-1234
6. Orlic D., Kajstura J., Chimenti S., Jakoniuk I., Anderson S.M., Li B., et al. Bone marrow cells regenerate infarcted myocardium. Nature 410 (2001) 701-705
7. Alison M.R., Poulsom R., Jeffery R., Dhillon A.P., Quaglia A., Jacob J., et al. Hepatocytes from non-hepatic adult stem cells. Nature 406 (2000) 257
8. Korbling M., Katz R.L., Khanna A., Ruifrok A.C., Rondon G., Albitar M., et al. Hepatocytes and epithelial cells of donor origin in recipients of peripheral-blood stem cells. N Engl J Med 346 (2002) 738-746
9. Petersen B.E., Bowen W.C., Patrene K.D., Mars W.M., Sullivan A.K., Murase N., et al. Bone marrow as a potential source of hepatic oval cells. Science 284 (1999) 1168-1170
10. Theise N.D., Badve S., Saxena R., Henegariu O., Sell S., Crawford J.M., et al. Derivation of hepatocytes from bone marrow cells in mice after radiation-induced myeloablation. Hepatology 31 (2000) 235-240
11. Kanazawa Y., and Verma I.M. Little evidence of bone marrow-derived hepatocytes in the replacement of injured liver. Proc Natl Acad Sci USA 100 (2003) 11850-11853
12. Franzke A. The role of G-CSF in adaptive immunity. Cytokine Growth Factor Rev 17 (2006) 235-244
13. Begley C.G., Lopez A.F., Nicola N.A., Warren D.J., Vadas M.A., Sanderson C.J., et al. Purified colony-stimulating factors enhance the survival of human neutrophils and eosinophils in vitro: a rapid and sensitive microassay for colony-stimulating factors. Blood 68 (1986) 162-166
14. Clark S.C., and Kamen R. The human hematopoietic colony-stimulating factors. Science 236 (1987) 1229-1237
15. Silver G.M., Gamelli R.L., and O'Reilly M. The beneficial effect of granulocyte colony-stimulating factor (G-CSF) in combination with gentamicin on survival after Pseudomonas burn wound infection. Surgery 106 (1989) 452-455
16. Gorgen I., Hartung T., Leist M., Niehorster M., Tiegs G., Uhlig S., et al. Granulocyte colony-stimulating factor treatment protects rodents against lipopolysaccharide-induced toxicity via suppression of systemic tumor necrosis factor-alpha. J Immunol 149 (1992) 918-924
17. Hebert J.C., O'Reilly M., and Gamelli R.L. Protective effect of recombinant human granulocyte colony-stimulating factor against pneumococcal infections in splenectomized mice. Arch Surg 125 (1990) 1075-1078
18. Takano H., Qin Y., Hasegawa H., Ueda K., Niitsuma Y., Ohtsuka M., et al. Effects of G-CSF on left ventricular remodeling and heart failure after acute myocardial infarction. J Mol Med 84 (2006) 185-193
19. Baert F.J., and Rutgeerts P.J. Medical therapies for ulcerative colitis and Crohn's disease. Curr Gastroenterol Rep 2 (2000) 446-450
20. Wasser S., and Tan C.E. Experimental models of hepatic fibrosis in the rat. Ann Acad Med Singapore 28 (1999) 109-111
21. Jezequel A.M., Mancini R., Rinaldesi M.L., Ballardini G., Fallani M., Bianchi F., et al. Dimethylnitrosamine-induced cirrhosis. Evidence for an immunological mechanism. J Hepatol 8 (1989) 42-52
22. Kimura K., Moriwaki H., Nagaki M., Saio M., Nakamoto Y., Naito M., et al. Pathogenic role of B cells in anti-CD40-induced necroinflammatory liver disease. Am J Pathol 168 (2006) 786-795
23. Takai S., Kimura K., Nagaki M., Satake S., Kamiki K., and Moriwaki H. Blockade of neutrophil elastase attenuates severe liver injury in hepatitis B transgenic mice. J Virol 79 (2005) 15142-15150
24. Boulton R., Woodman A., Calnan D., Selden C., Tam F., and Hodgson H. Nonparenchymal cells from regenerating rat liver generate interleukin-1alpha and -1beta: a mechanism of negative regulation of hepatocyte proliferation. Hepatology 26 (1997) 49-58
25. Nagaki M., Muto Y., Ohnishi H., and Moriwaki H. Significance of tumor necrosis factor (TNF) and interleukin-1 (IL-1) in the pathogenesis of fulminant hepatitis: possible involvement of serine protease in TNF-mediated liver injury. Gastroenterol Jpn 26 (1991) 448-455
26. Morgan D.O. Principles of CDK regulation. Nature 374 (1995) 131-134
27. Peter M., and Herskowitz I. Joining the complex: cyclin-dependent kinase inhibitory proteins and the cell cycle. Cell 79 (1994) 181-184
28. Sherr C.J., and Roberts J.M. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 13 (1999) 1501-1512
29. Fleig W.E. Liver-specific growth factors. Scand J Gastroenterol Suppl 151 (1988) 31-36
30. Shaklee C.L., Guo J., Faggioni R., Fantuzzi G., and Senaldi G. Pretreatment with granulocyte-colony stimulating factor decreases lipopolysaccharide-induced interferon-gamma production in mice in association with the production of interleukin-18. Cytokine 25 (2004) 119-126
31. Aoki Y., Hiromatsu K., Kobayashi N., Hotta T., Saito H., Igarashi H., et al. Protective effect of granulocyte colony-stimulating factor against T-cell-meditated lethal shock triggered by superantigens. Blood 86 (1995) 1420-1427
32. Egi H., Hayamizu K., Yoshimitsu M., Shimamoto F., Oishi K., Ohmori I., et al. Regulation of T helper type-1 immunity in hapten-induced colitis by host pretreatment with granulocyte colony-stimulating factor. Cytokine 23 (2003) 23-30
33. Lawlor K.E., Campbell I.K., Metcalf D., O'Donnell K., van Nieuwenhuijze A., Roberts A.W., et al. Critical role for granulocyte colony-stimulating factor in inflammatory arthritis. Proc Natl Acad Sci USA 101 (2004) 11398-11403
34. Dejaco C., Lichtenberger C., Miehsler W., Oberhuber G., Herbst F., Vogelsang H., et al. An open-label pilot study of granulocyte colony-stimulating factor for the treatment of severe endoscopic postoperative recurrence in Crohn's disease. Digestion 68 (2003) 63-70
35. White K., and Cebon J. Transient hypoxaemia during neutrophil recovery in febrile patients. Lancet 345 (1995) 1022-1024
36. Snowden J.A., Biggs J.C., Millilen S.T., Fuller A., Staniforth D., Passuello F., et al. A randomised, blinded, placebo-controlled, dose escalation study of the tolerability and efficacy of filgrastim for haemopoietic stem cell mobilisation in patients with severe active rheumatoid arthritis. Bone Marrow Transplant 22 (1998) 1035-1041
37. Theocharis S.E., Papadimitriou L.J., Retsou Z.P., Margeli A.P., Ninos S.S., Papadimitriou J.D., et al. Granulocyte-colony stimulating factor administration ameliorates liver regeneration in animal model of fulminant hepatic failure and encephalopathy. Dig Dis Sci 48 (2003) 1797-1803
38. Yannaki E., Athanasiou E., Xagorari A., Constantinou V., Batsis I., Kaloyannidis P., et al. G-CSF-primed hematopoietic stem cells or G-CSF per se accelerate recovery and improve survival after liver injury, predominantly by promoting endogenous repair programs. Exp Hematol 33 (2005) 108-119
39. Ono M., Yu B., Hardison E.G., Mastrangelo M.A., and Tweardy D.J. Increased susceptibility to liver injury after hemorrhagic shock in rats chronically fed ethanol: role of nuclear factor-kappa B, interleukin-6, and granulocyte colony-stimulating factor. Shock 21 (2004) 519-525
40. Petersen B.E., Zajac V.F., and Michalopoulos G.K. Hepatic oval cell activation in response to injury following chemically induced periportal or pericentral damage in rats. Hepatology 27 (1998) 1030-1038
41. Yang S., Koteish A., Lin H., Huang J., Roskams T., Dawson V., et al. Oval cells compensate for damage and replicative senescence of mature hepatocytes in mice with fatty liver disease. Hepatology 39 (2004) 403-411
42. Dinarello C.A. Interleukin-1 and interleukin-1 antagonism. Blood 77 (1991) 1627-1652